INNSBRUCK, AUSTRIA — MED-EL co-founder and CEO Dr. Ingeborg Hochmair has been named a recipient of the Honda Prize 2026, adding to a series of recent honors recognizing the scientists and engineers whose work contributed to the development of the modern cochlear implant.
The announcement follows the selection of Hochmair and her husband and MED-EL co-founder, Dr. Erwin Hochmair, as recipients of the 2026 Richard N. Merkin Prize in Biomedical Technology.
The two awards recognize contributions spanning nearly five decades of cochlear implant research, engineering, clinical development, and adoption.
Honda Prize Recognizes Cochlear Implant Development
Presented annually by the Honda Foundation, the Honda Prize recognizes scientific and technological achievements intended to contribute to human well-being. Hochmair shares the 2026 award with Australian physician and cochlear implant researcher Dr. Graeme Clark.
The Foundation cited Hochmair’s contributions to the research, development, clinical application, and global adoption of multichannel cochlear implant technology.
Hochmair began working in cochlear implant research during the 1970s. Together with Erwin Hochmair, she developed a microelectronic multichannel cochlear implant that was successfully implanted at the University of Vienna in 1977. Their research eventually led to the founding of MED-EL and helped establish technology that contributed to the development of modern cochlear implant systems.
“It is a great honor to be named a recipient of the Honda Prize. The award’s vision that scientific and technological progress should ultimately serve people resonates strongly with the field of cochlear implants. This recognition reflects the dedication of many researchers, clinicians, engineers, rehabilitation specialists, and, most importantly, implant recipients who have contributed to the development and advancement of cochlear implant technology over the past decades. Together, we have helped create opportunities for people around the world to hear, communicate, and participate more fully in life.”
–Ingeborg Hochmair
The Honda Prize was established in 1980 and is one of Japan’s international science and technology awards. The 2026 award ceremony is scheduled for November 16 in Tokyo. This year’s laureates will receive a medal and certificate and share a ¥10 million cash prize.
Hochmairs Among Five Recipients of 2026 Merkin Prize
Ingeborg and Erwin Hochmair have also been named recipients of the 2026 Richard N. Merkin Prize in Biomedical Technology, administered by the Broad Institute of MIT and Harvard.
The Hochmairs share the award with Graeme Clark, Michael Merzenich, and Blake Wilson, recognizing their collective contributions to the development of the modern cochlear implant. The $400,000 prize recognizes biomedical technologies with demonstrated impact on human health and the individuals whose work helped make those technologies possible.
“The success of the cochlear implant depended on multiple scientific and engineering breakthroughs achieved across disciplines and countries over many decades,” said Harold Varmus, Nobel Laureate and chair of the Merkin Prize Selection Committee. “The Merkin Prize recognizes individuals whose contributions were essential to one of the most impactful medical technologies of our time.”
The Hochmairs’ work began at the Technical University of Vienna in the 1970s, where they pursued the use of electrical stimulation of the auditory nerve to provide access to sound for people with severe-to-profound hearing loss. Their work culminated in the 1977 implantation and subsequently contributed to advances in multichannel cochlear implant technology.
“We are deeply honored to receive this recognition,” said Ingeborg Hochmair. “The cochlear implant is the result of decades of collaboration between engineers, scientists, clinicians, and hearing implant recipients. This award celebrates what can be achieved when innovation is guided by the goal of improving people’s lives.”
Erwin Hochmair added:
“Developing the cochlear implant required perseverance, curiosity, and the willingness to challenge conventional thinking. We are grateful to see how this technology has evolved and how many people around the world have benefited from it.”
Nearly five decades after the Hochmairs’ early cochlear implant work, cochlear implantation has become an established intervention for children and adults with significant hearing loss, with candidacy and clinical applications continuing to expand.
More information about the Richard N. Merkin Prize is available from the Merkin Prize, while additional information about the Honda Prize is available from the Honda Foundation.
About MED-EL
MED-EL is an Austrian-based, privately owned hearing implant company co-founded by Ingeborg and Erwin Hochmair. The company develops cochlear and middle ear implant systems, electric-acoustic stimulation systems, auditory brainstem implants, and surgical and non-surgical bone conduction devices. MED-EL has more than 3,300 employees representing approximately 90 nationalities across 30 locations worldwide.
Source: MED-EL
